ArticleInternational journal of molecular sciences2022

Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis.

Marina Boziki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.